REVIEW
|
doi:10.20944/preprints202410.1831.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Antibody-drug conjugates; metastatic breast cancer; predictive factors; HER2; TROP-2; trastuzumab emtansine; trastuzumab deruxtecan; sacituzumab govitecan
Online: 24 October 2024 (04:36:33 CEST)